Authors,Author(s) ID,Title,Year,Source tittle,Cited by,DOI,Country,Document Type,City,Access Type,aggregationType,EID
Miller K.D.,,"Phase IIa trial of trastuzumab emtansine with pertuzumab for patients with human epidermal growth factor receptor 2-positive, locally advanced, or metastatic breast cancer",2014,Journal of Clinical Oncology,58,10.1200/JCO.2013.52.6590,United States,Article,Indianapolis,0,Journal,2-s2.0-84902973417
Welslau M.,,"Patient-reported outcomes from EMILIA, a randomized phase 3 study of trastuzumab emtansine (T-DM1) versus capecitabine and lapatinib in human epidermal growth factor receptor 2-positive locally advanced or metastatic breast cancer",2014,Cancer,76,10.1002/cncr.28465,Germany,Article,Aschaffenburg,1,Journal,2-s2.0-84896704753
Cummings M.C.,,Metastatic progression of breast cancer: Insights from 50 years of autopsies,2014,Journal of Pathology,79,10.1002/path.4288,Australia;Australia;Australia,Review,Brisbane;Brisbane;Brisbane,1,Journal,2-s2.0-84890054152
Williams P.,,Breast cancer mortality vs. exercise and breast size in runners and walkers,2013,PLoS ONE,17,10.1371/journal.pone.0080616,United States,Article,Berkeley,1,Journal,2-s2.0-84892592823
Gucalp A.,,"Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic breast cancer",2013,Clinical Cancer Research,343,10.1158/1078-0432.CCR-12-3327,United States;United States,Article,New York;New York,1,Journal,2-s2.0-84886425456
Westley R.,,"A twenty-first century cancer epidemic caused by obesity: The involvement of insulin, diabetes, and insulin-like growth factors",2013,International Journal of Endocrinology,37,10.1155/2013/632461,United Kingdom,Review,Newcastle,1,Journal,2-s2.0-84883144613
Tebbutt N.,,Targeting the ERBB family in cancer: Couples therapy,2013,Nature Reviews Cancer,209,10.1038/nrc3559,Australia,Review,Melbourne,0,Journal,2-s2.0-84883179862
Xu S.,,"1-Phenyl-4-benzoyl-1H-1,2,3-triazoles as orally bioavailable transcriptional function suppressors of Estrogen-related receptor α",2013,Journal of Medicinal Chemistry,46,10.1021/jm4003928,China;China,Article,Guangzhou;Beijing,0,Journal,2-s2.0-84879034381
Zagouri F.,,Intrathecal administration of trastuzumab for the treatment of meningeal carcinomatosis in HER2-positive metastatic breast cancer: A systematic review and pooled analysis,2013,Breast Cancer Research and Treatment,76,10.1007/s10549-013-2525-y,Greece;Austria,Review,Athens;Vienna,0,Journal,2-s2.0-84877580501
Zardavas D.,,Emerging targeted agents in metastatic breast cancer,2013,Nature Reviews Clinical Oncology,121,10.1038/nrclinonc.2013.29,Belgium,Review,Brussels,0,Journal,2-s2.0-84875752240
Johnson R.H.,,"Incidence of breast cancer with distant involvement among women in the United States, 1976 to 2009",2013,JAMA - Journal of the American Medical Association,179,10.1001/jama.2013.776,United States,Article,Seattle,1,Journal,2-s2.0-84874375934
Manavathi B.,,Derailed estrogen signaling and breast cancer: An authentic couple,2013,Endocrine Reviews,63,10.1210/er.2011-1057,India,Review,Hyderabad,1,Journal,2-s2.0-84874669929
Baum M.,,Harms from breast cancer screening outweigh benefits if death caused by treatment is included,2013,BMJ (Online),61,10.1136/bmj.f385,United Kingdom,Note,London,0,Journal,2-s2.0-84873023439
Krzysik-Walker S.,,The biarylpyrazole compound AM251 alters mitochondrial physiology via proteolytic degradation of ERRα,2013,Molecular Pharmacology,7,10.1124/mol.112.082651,United States,Article,Bethesda,0,Journal,2-s2.0-84871562646
Hatzivassiliou G.,,Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers,2013,Nature,177,10.1038/nature12441,United States,Article,San Francisco,0,Journal,2-s2.0-84884127318
Cuzick J.,,Selective oestrogen receptor modulators in prevention of breast cancer: An updated meta-analysis of individual participant data,2013,The Lancet,272,10.1016/S0140-6736(13)60140-3,United Kingdom,Article,London,0,Journal,2-s2.0-84878107936
Davies C.,,"Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial",2013,The Lancet,1077,10.1016/S0140-6736(12)61963-1,United Kingdom,Article,Oxford,0,Journal,2-s2.0-84874745627
Sestak I.,,Preventive therapy for breast cancer,2012,Current Oncology Reports,4,10.1007/s11912-012-0273-5,United Kingdom,Article,London,0,Journal,2-s2.0-84870541493
Zardavas D.,,Phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway inhibition: A breakthrough in the management of luminal (ER +HER2-) breast cancers?,2012,Current Opinion in Oncology,41,10.1097/CCO.0b013e328358a2b5,Belgium,Review,Brussels,0,Journal,2-s2.0-84868212708
Ibrahim Y.H.,,PI3K inhibition impairs BRCA1/2 expression and sensitizes BRCA-proficient triple-negative breast cancer to PARP inhibition,2012,Cancer Discovery,314,10.1158/2159-8290.CD-11-0348,Spain,Article,Barcelona,1,Journal,2-s2.0-84866681744
McCullough L.,,"Fat or fit: The joint effects of physical activity, weight gain, and body size on breast cancer risk",2012,Cancer,34,10.1002/cncr.27433,United States,Article,Chapel Hill,0,Journal,2-s2.0-84866523832
Yarden Y.,,"The ERBB network: At last, cancer therapy meets systems biology",2012,Nature Reviews Cancer,436,10.1038/nrc3309,Israel,Review,Rehovot,0,Journal,2-s2.0-84864367360
Wong C.,,Inhibitors of hypoxia-inducible factor 1 block breast cancer metastatic niche formation and lung metastasis,2012,Journal of Molecular Medicine,135,10.1007/s00109-011-0855-y,Hong Kong;United States,Article,Pokfulam;Baltimore,0,Journal,2-s2.0-84865149277
Zhao Y.,,MiR-137 targets estrogen-related receptor alpha and impairs the proliferative and migratory capacity of breast cancer cells,2012,PLoS ONE,90,10.1371/journal.pone.0039102,China,Article,Chongqing,1,Journal,2-s2.0-84862489809
Pollak M.,,The insulin and insulin-like growth factor receptor family in neoplasia: An update,2012,Nature Reviews Cancer,687,10.1038/nrc3215,Canada,Review,Montreal,0,Journal,2-s2.0-84857640868
Bendell J.C.,,"Phase I, dose-escalation study of BKM120, an oral pan-class I PI3K inhibitor, in patients with advanced solid tumors",2012,Journal of Clinical Oncology,488,10.1200/JCO.2011.36.1360,United States,Article,Nashville,0,Journal,2-s2.0-84856071447
Pérez-Schindler J.,,The corepressor NCoR1 antagonizes PGC-1α and estrogen-related receptor α in the regulation of skeletal muscle function and oxidative metabolism,2012,Molecular and Cellular Biology,51,10.1128/MCB.00877-12,Switzerland,Article,Basel,1,Journal,2-s2.0-84871902783
Arteaga C.,,Treatment of HER2-positive breast cancer: Current status and future perspectives,2012,Nature Reviews Clinical Oncology,523,10.1038/nrclinonc.2011.177,United States,Review,Nashville,0,Journal,2-s2.0-84655162706
Marmot M.,,The benefits and harms of breast cancer screening: An independent review,2012,The Lancet,753,10.1016/S0140-6736(12)61611-0,United Kingdom,Review,London,0,Journal,2-s2.0-84869083222
Peng L.,,"Identification of pyrido[1,2-α]pyrimidine-4-ones as new molecules improving the transcriptional functions of estrogen-related receptor α",2011,Journal of Medicinal Chemistry,39,10.1021/jm200976s,China;China,Article,Guangzhou;Beijing,0,Journal,2-s2.0-80455144761
Chang C.,,"The Metabolic Regulator ERRα, a Downstream Target of HER2/IGF-1R, as a Therapeutic Target in Breast Cancer",2011,Cancer Cell,90,10.1016/j.ccr.2011.08.023,United States,Article,Durham,1,Journal,2-s2.0-80054716866
Fiori J.,,The cannabinoid receptor inverse agonist AM251 regulates the expression of the EGF receptor and its ligands via destabilization of oestrogen-related receptor α protein,2011,British Journal of Pharmacology,14,10.1111/j.1476-5381.2011.01384.x,United States,Article,Bethesda,0,Journal,2-s2.0-80052584426
Le Romancer M.,,Cracking the estrogen receptor's posttranslational code in breast tumors,2011,Endocrine Reviews,158,10.1210/er.2010-0016,France;France;France;France;France,Review,Lyon;Villeurbanne;Lyon;Paris;Paris,1,Journal,2-s2.0-81255186483
Pandya K.,,Targeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrence,2011,British Journal of Cancer,88,10.1038/bjc.2011.321,United States,Article,Chicago,1,Journal,2-s2.0-80052494506
Fradet A.,,Dual function of ERRα in breast cancer and bone metastasis formation: Implication of VEGF and osteoprotegerin,2011,Cancer Research,53,10.1158/0008-5472.CAN-11-1431,France;France,Article,Lyon;Paris,1,Journal,2-s2.0-80052213519
Musgrove E.,,Cyclin D as a therapeutic target in cancer,2011,Nature Reviews Cancer,809,10.1038/nrc3090,Australia;Australia,Review,Sydney;Sydney,0,Journal,2-s2.0-79960836823
Tiraby C.,,Estrogen-related receptor gamma promotes mesenchymal-to-epithelial transition and suppresses breast tumor growth,2011,Cancer Research,48,10.1158/0008-5472.CAN-10-1315,United States,Article,San Diego,1,Journal,2-s2.0-79953294523
Chao W.R.,,SR16388: A steroidal antiangiogenic agent with potent inhibitory effect on tumor growth in vivo,2011,Angiogenesis,6,10.1007/s10456-010-9191-z,United States,Article,Menlo Park,0,Journal,2-s2.0-79952282326
Patch R.J.,,Identification of diaryl ether-based ligands for estrogen-related receptor α as potential antidiabetic agents,2011,Journal of Medicinal Chemistry,63,10.1021/jm101063h,United States,Article,Raritan,0,Journal,2-s2.0-79851480621
Rios J.,,PARP inhibitors in breast cancer: BRCA and beyond,2011,Oncology,44,,United States,Review,Pittsburgh,0,Journal,2-s2.0-80355135233
Davison Z.,,Insulin-like growth factor- dependent proliferation and survival of triple-negative breast cancer cells: Implications for therapy,2011,Neoplasia,90,10.1593/neo.101590,United Kingdom,Article,Newcastle,1,Journal,2-s2.0-79958120631
Deblois G.,,Transcriptional control of the ERBB2 amplicon by ERRa and PGC-1b promotes mammary gland tumorigenesis,2010,Cancer Research,55,10.1158/0008-5472.CAN-10-2840,Canada;Canada,Article,Montreal;Montreal,1,Journal,2-s2.0-78650387482
Dwyer M.,,WNT11 expression is induced by estrogen-related receptor α and β-catenin and acts in an autocrine manner to increase cancer cell migration,2010,Cancer Research,93,10.1158/0008-5472.CAN-10-0226,United States,Article,Durham,1,Journal,2-s2.0-78549241322
Hershman D.,,"Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients",2010,Journal of Clinical Oncology,475,10.1200/JCO.2009.25.9655,,Article,,0,Journal,2-s2.0-77957936884
Duellman S.,,A novel steroidal inhibitor of estrogen-related receptor α (ERRα),2010,Biochemical Pharmacology,24,10.1016/j.bcp.2010.05.024,United States,Article,Menlo Park,0,Journal,2-s2.0-77954819506
Van Herk-Sukel M.,,Half of breast cancer patients discontinue tamoxifen and any endocrine treatment before the end of the recommended treatment period of 5 years: A population-based analysis,2010,Breast Cancer Research and Treatment,70,10.1007/s10549-009-0724-3,Netherlands,Article,Utrecht,0,Journal,2-s2.0-77955559438
Sestak I.,,Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: An exploratory analysis from the ATAC trial,2010,Journal of Clinical Oncology,194,10.1200/JCO.2009.27.2021,,Article,,0,Journal,2-s2.0-77955296639
Wang Y.,,Troglitazone is an estrogen-related receptor α and γ inverse agonist,2010,Biochemical Pharmacology,17,10.1016/j.bcp.2010.03.013,China,Article,Guangzhou,0,Journal,2-s2.0-77952293181
Wang J.,,Oestrogen-related receptor alpha inverse agonist XCT-790 arrests A549 lung cancer cell population growth by inducing mitochondrial reactive oxygen species production,2010,Cell Proliferation,37,10.1111/j.1365-2184.2009.00659.x,China,Article,Guangzhou,0,Journal,2-s2.0-77649216353
Wilson B.,,An acetylation switch modulates the transcriptional activity of estrogen-related receptor α,2010,Molecular Endocrinology,109,10.1210/me.2009-0441,Canada,Article,Montreal,1,Journal,2-s2.0-77954831404
Desgrosellier J.,,Integrins in cancer: Biological implications and therapeutic opportunities,2010,Nature Reviews Cancer,2154,10.1038/nrc2748,United States,Review,San Diego,0,Journal,2-s2.0-72949119124
Heyes G.J.,,Mammography - Oncogenecity at low doses,2009,Journal of Radiological Protection,38,10.1088/0952-4746/29/2A/S08,United Kingdom,Article,Birmingham,0,Journal,2-s2.0-69149102293
Teyssier C.,,Absence of ERRα in female mice confers resistance to bone loss induced by age or estrogen-deficiency,2009,PLoS ONE,30,10.1371/journal.pone.0007942,France,Article,Lyon,1,Journal,2-s2.0-70949105650
Wu F.,,Estrogen-related receptor α (ERRα) inverse agonist XCT-790 induces cell death in chemotherapeutic resistant cancer cells,2009,Chemico-Biological Interactions,35,10.1016/j.cbi.2009.05.008,China,Article,Guangzhou,0,Journal,2-s2.0-68849108383
Delhon I.,,Absence of estrogen receptor-related-α increases osteoblastic differentiation and cancellous bone mineral density,2009,Endocrinology,47,10.1210/en.2009-0121,Switzerland,Article,Basel,1,Journal,2-s2.0-70349333351
Nie Y.,,Suppressing the activity of ERRα in 3T3-L1 adipocytes reduces mitochondrial biogenesis but enhances glycolysis and basal glucose uptake,2009,Journal of Cellular and Molecular Medicine,19,10.1111/j.1582-4934.2008.00382.x,China;China,Article,Guangzhou;Hefei,0,Journal,2-s2.0-77449138454
Xu J.,,Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family,2009,Nature Reviews Cancer,318,10.1038/nrc2695,China;United States,Review,Luzhou;Houston,0,Journal,2-s2.0-69249110003
Bianco S.,,Modulating estrogen receptor-related receptor-α activity inhibits cell proliferation,2009,Journal of Biological Chemistry,66,10.1074/jbc.M109.028191,France,Article,Villeurbanne,1,Journal,2-s2.0-69949171075
Deblois G.,,Genome-wide identification of direct target genes implicates estrogen-related receptor α as a determinant of breast cancer heterogeneity,2009,Cancer Research,108,10.1158/0008-5472.CAN-09-1251,Canada;Canada,Article,Montreal;Montreal,1,Journal,2-s2.0-68049129872
Huang E.,,A CXCR4 Antagonist CTCE-9908 Inhibits Primary Tumor Growth and Metastasis of Breast Cancer<sup>1</sup>,2009,Journal of Surgical Research,113,10.1016/j.jss.2008.06.044,United States,Article,Houston,0,Journal,2-s2.0-67650992011
Chen L.,,Estrogen-related receptor α inverse agonist enhances basal glucose uptake in myotubes through reactive oxygen species,2009,Biological and Pharmaceutical Bulletin,12,10.1248/bpb.32.1199,China,Article,Guangzhou,1,Journal,2-s2.0-67650711167
Wright P.K.,,"Estrogen regulates vesicle trafficking gene expression in EFF-3, EFM-19 and MCF-7 breast cancer cells",2009,International Journal of Clinical and Experimental Pathology,23,,United Kingdom;United Kingdom,Article,Newcastle;Newcastle,0,Journal,2-s2.0-66949112236
Chisamore M.,,Characterization of a novel small molecule subtype specific estrogen-related receptor α antagonist in MCF-7 breast cancer cells,2009,PLoS ONE,33,10.1371/journal.pone.0005624,United States;United States,Article,Newark;Kenilworth,1,Journal,2-s2.0-66249137467
Chisamore M.,,Estrogen-related receptor-α antagonist inhibits both estrogen receptor-positive and estrogen receptor-negative breast tumor growth in mouse xenografts,2009,Molecular Cancer Therapeutics,57,10.1158/1535-7163.MCT-08-1028,United States;United States,Article,Piscataway;Kenilworth,1,Journal,2-s2.0-66249109135
Allen N.E.,,Moderate alcohol intake and cancer incidence in women,2009,Journal of the National Cancer Institute,382,10.1093/jnci/djn514,United Kingdom,Article,Oxford,1,Journal,2-s2.0-62349114240
Wang J.,,Kaempferol is an estrogen-related receptor α and γ inverse agonist,2009,FEBS Letters,53,10.1016/j.febslet.2009.01.030,China,Article,Guangzhou,1,Journal,2-s2.0-59849083230
Stein R.A.,,Estrogen-related receptor α is critical for the growth of estrogen receptor-negative breast cancer,2008,Cancer Research,101,10.1158/0008-5472.CAN-08-1594,United States,Article,Durham,1,Journal,2-s2.0-55349107225
Chisamore M.,,Identification of small molecule estrogen-related receptor α-specific antagonists and homology modeling to predict the molecular determinants as the basis for selectivity over ERRβ and ERRγ,2008,Drug Development Research,12,10.1002/ddr.20246,United States;United States,Article,Newark;Kenilworth,0,Journal,2-s2.0-50849126802
Tremblay A.,,Phosphorylation-dependent sumoylation regulates estrogen-related receptor-β and -γ transcriptional activity through a synergy control motif,2008,Molecular Endocrinology,63,10.1210/me.2007-0357,Canada;Canada,Article,Montreal;Montreal,1,Journal,2-s2.0-40849126935
Hyatt S.,,On the intractability of estrogen-related receptor α as a target for activation by small molecules,2007,Journal of Medicinal Chemistry,18,10.1021/jm7012387,United States,Article,Philadelphia,0,Journal,2-s2.0-37349006914
Clemmons D.,,"Modifying IGF1 activity: An approach to treat endocrine disorders, atherosclerosis and cancer",2007,Nature Reviews Drug Discovery,241,10.1038/nrd2359,United States,Review,Chapel Hill,0,Journal,2-s2.0-34848845313
Lanvin O.,,"Potentiation of ICI182,780 (Fulvestrant)-induced estrogen receptor-α degradation by the estrogen receptor-related receptor-α inverse agonist XCT790",2007,Journal of Biological Chemistry,59,10.1074/jbc.M704295200,France;France,Article,Lyon;Lyon,1,Journal,2-s2.0-35349008456
Kallen J.,,Crystal structure of human estrogen-related receptor α in complex with a synthetic inverse agonist reveals its novel molecular mechanism,2007,Journal of Biological Chemistry,53,10.1074/jbc.M703337200,Switzerland,Article,Basel,1,Journal,2-s2.0-34548146568
Huss J.,,The Nuclear Receptor ERRα Is Required for the Bioenergetic and Functional Adaptation to Cardiac Pressure Overload,2007,Cell Metabolism,186,10.1016/j.cmet.2007.06.005,United States,Article,St. Louis,1,Journal,2-s2.0-34347248013
Gori S.,,"Central nervous system metastases in HER-2-positive metastatic breast cancer patients treated with trastuzumab: Incidence, survival, and risk factors",2007,Oncologist,100,10.1634/theoncologist.12-7-766,Italy,Article,Perugia,0,Journal,2-s2.0-34548241776
Chen E.,,Adaptation of energy metabolism in breast cancer brain metastases,2007,Cancer Research,200,10.1158/0008-5472.CAN-06-3137,United States,Article,San Diego,1,Journal,2-s2.0-33847755430
Ariazi E.,,Estrogen-related receptor α1 transcriptional activities are regulated in part via the ErbB2/HER2 signaling pathway,2007,Molecular Cancer Research,76,10.1158/1541-7786.MCR-06-0227,United States,Article,Madison,1,Journal,2-s2.0-33846951523
Gaillard S.,,Receptor-Selective Coactivators as Tools to Define the Biology of Specific Receptor-Coactivator Pairs,2006,Molecular Cell,50,10.1016/j.molcel.2006.10.012,United States,Article,Durham,1,Journal,2-s2.0-33751503523
Castet A.,,Receptor-interacting protein 140 differentially regulates estrogen receptor-related receptor transactivation depending on target genes,2006,Molecular Endocrinology,76,10.1210/me.2005-0227,France,Article,Paris,1,Journal,2-s2.0-33746086158
Watanabe A.,,Function of estrogen-related receptor α in human endometrial cancer,2006,Journal of Clinical Endocrinology and Metabolism,27,10.1210/jc.2005-1990,Japan,Article,Kyoto,1,Journal,2-s2.0-33646070946
Barry J.,,Epidermal growth factor-induced signaling in breast cancer cells results in selective target gene activation by orphan nuclear receptor estrogen-related receptor α,2005,Cancer Research,68,10.1158/0008-5472.CAN-05-0922,Canada,Article,Montreal,1,Journal,2-s2.0-22244480341
Kallen J.,,Evidence for ligand-independent transcriptional activation of the human estrogen-related receptor α (ERRα): Crystal structure of ERRα ligand binding domain in complex with peroxisome proliferator-activated receptor coactivator-1α,2004,Journal of Biological Chemistry,163,10.1074/jbc.M407999200,Switzerland,Article,Basel,1,Journal,2-s2.0-10344247702
Busch B.B.,,Identification of a selective inverse agonist for the orphan nuclear receptor estrogen-related receptor α,2004,Journal of Medicinal Chemistry,109,10.1021/jm049334f,United States,Article,Alameda,0,Journal,2-s2.0-7444271980
Huss J.M.,,Estrogen-related receptor α directs peroxisome proliferator-activated receptor α signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle,2004,Molecular and Cellular Biology,345,10.1128/MCB.24.20.9079-9091.2004,United States,Article,St. Louis,1,Journal,2-s2.0-4744371376
Suzuki T.,,Estrogen-related receptor α in human breast carcinoma as a potent prognostic factor,2004,Cancer Research,176,10.1158/0008-5472.CAN-04-0250,Japan,Article,Sendai,1,Journal,2-s2.0-3042699992
Mootha V.K.,,Errα and Gabpa/b specify PGC-1α-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle,2004,Proceedings of the National Academy of Sciences of the United States of America,506,10.1073/pnas.0401401101,United States;United States;United States,Article,Cambridge;Boston;Cambridge,1,Journal,2-s2.0-2342477730
Suetsugi M.,,Flavone and Isoflavone Phytoestrogens Are Agonists of Estrogen-Related Receptors,2003,Molecular Cancer Research,139,,United States,Article,Duarte,0,Journal,2-s2.0-0344011490
Luo J.,,Reduced Fat Mass in Mice Lacking Orphan Nuclear Receptor Estrogen-Related Receptor α,2003,Molecular and Cellular Biology,276,10.1128/MCB.23.22.7947-7956.2003,Canada,Article,Montreal,1,Journal,2-s2.0-0242580188
Mootha V.K.,,PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes,2003,Nature Genetics,4404,10.1038/ng1180,United States;United States;United States,Article,Cambridge;Boston;Boston,0,Journal,2-s2.0-0038054341
Lamar C.,,Serum sex hormones and breast cancer risk factors in postmenopausal women,2003,Cancer Epidemiology Biomarkers and Prevention,47,,United States,Article,Bethesda,0,Journal,2-s2.0-0037390243
Ariazi E.,,"Estrogen-related receptor α and estrogen-related receptor γ associate with unfavorable and favorable biomarkers, respectively, in human breast cancer",2002,Cancer Research,225,,United States,Article,Madison,0,Journal,2-s2.0-0037112441
Kraus R.,,Estrogen-related receptor α1 actively antagonizes estrogen receptor-regulated transcription in MCF-7 mammary cells,2002,Journal of Biological Chemistry,97,10.1074/jbc.M202952200,United States,Article,Madison,1,Journal,2-s2.0-0037025312
Kressler D.,,The PGC-1-related protein PERC is a selective coactivator of estrogen receptor α,2002,Journal of Biological Chemistry,180,10.1074/jbc.M201134200,Switzerland,Article,Basel,1,Journal,2-s2.0-0037134493
Lin J.,,"Peroxisome proliferator-activated receptor γ coactivator 1β (PGC-1β), a novel PGC-1-related transcription coactivator associated with host cell factor",2002,Journal of Biological Chemistry,411,10.1074/jbc.C100631200,United States,Article,Boston,1,Journal,2-s2.0-0037127204
Prest S.J.,,"The estrogen-regulated protein, TFF1, stimulates migration of human breast cancer cells.",2002,The FASEB journal : official publication of the Federation of American Societies for Experimental Biology,139,10.1096/fj.01-0498fje,United Kingdom,Article,Newcastle,0,Journal,2-s2.0-0036550954
Beral V.,,Familial breast cancer: Collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease,2001,Lancet,733,10.1016/S0140-6736(01)06524-2,United Kingdom,Article,Oxford,0,Journal,2-s2.0-0035960431
Lu D.,,Transcriptional regulation of the estrogen-inducible pS2 breast cancer marker gene by the ERR family of orphan nuclear receptors,2001,Cancer Research,158,,Canada,Article,Montreal,0,Journal,2-s2.0-0035883862
Yoon J.,,Control of hepatic gluconeogenesis through the transcriptional coaotivator PGC-1,2001,Nature,1377,10.1038/35093050,United States,Article,Boston,0,Journal,2-s2.0-0035855858
Coward P.,,4-Hydroxytamoxifen binds to and deactivates the estrogen-related receptor γ,2001,Proceedings of the National Academy of Sciences of the United States of America,220,10.1073/pnas.151244398,United States,Article,Thousand Oaks,1,Journal,2-s2.0-0035902557
Klinge C.M.,,Estrogen receptor interaction with estrogen response elements,2001,Nucleic Acids Research,704,10.1093/nar/29.14.2905,United States,Article,Louisville,1,Journal,2-s2.0-0035878743
Zhang Z.,,Estrogen receptor α and estrogen receptor-related receptor α1 compete for binding and coactivator,2001,Molecular and Cellular Endocrinology,58,10.1016/S0303-7207(00)00372-5,United States,Article,Research Triangle Park,0,Journal,2-s2.0-0035857465
Blair R.M.,,The estrogen receptor relative binding affinities of 188 natural and xenochemicals: Structural diversity of ligands,2000,Toxicological Sciences,619,10.1093/toxsci/54.1.138,United States,Article,Jeffersonville,1,Journal,2-s2.0-0034020453
Yang C.,,"Two organochlorine pesticides, toxaphene and chlordane, are antagonists for estrogen-related receptor α-1 orphan receptor",1999,Cancer Research,96,,United States,Article,Duarte,0,Journal,2-s2.0-0033567916
Chen F.,,Identification of two hERR2-related novel nuclear receptors utilizing bioinformatics and inverse PCR,1999,Gene,51,10.1016/S0378-1119(98)00619-2,United States,Article,Kenilworth,0,Journal,2-s2.0-0033522229
Shiau A.,,The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen,1998,Cell,2082,10.1016/S0092-8674(00)81717-1,United States,Article,San Francisco,1,Journal,2-s2.0-0032446607
Yang C.,,Modulation of aromatase expression in the breast tissue by ERRα-1 orphan receptor,1998,Cancer Research,121,,United States,Article,Duarte,0,Journal,2-s2.0-0032535306
Westley B.,,Interactions between the oestrogen and insulin-like growth factor signalling pathways in the control of breast epithelial cell proliferation,1998,Biochemical Society Symposium,31,,United Kingdom,Article,Newcastle,0,Book Series,2-s2.0-0031605753
Vanacker J.,,Activation of the osteopontin promoter by the orphan nuclear receptor estrogen receptor related α,1998,Cell Growth and Differentiation,96,,France,Article,Lyon,0,Journal,2-s2.0-0032411383
Vanacker J.,,Activation of the thyroid hormone receptor a gene promoter by the orphan nuclear receptor ERRα,1998,Oncogene,63,10.1038/sj.onc.1202167,France,Article,Lyon,1,Journal,2-s2.0-0032511895
Abe O.,,Tamoxifen for early breast cancer: An overview of the randomised trials,1998,The Lancet,3592,10.1016/S0140-6736(97)11423-4,Japan,Article,Tokyo,0,Journal,2-s2.0-0032537396
Puigserver P.,,A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis,1998,Cell,2704,10.1016/S0092-8674(00)81410-5,United States,Article,Boston,1,Journal,2-s2.0-0032549811
Brzozowski A.,,Molecular basis of agonism and antagonism in the oestrogen receptor,1997,Nature,2733,10.1038/39645,United Kingdom,Article,York,0,Journal,2-s2.0-0030667676
Bonnelye E.,,The ERR-1 orphan receptor is a transcriptional activator expressed during bone development,1997,Molecular Endocrinology,122,10.1210/mend.11.7.9948,France,Article,Lille,1,Journal,2-s2.0-0030961744
Kuiper G.,,Cloning of a novel estrogen receptor expressed in rat prostate and ovary,1996,Proceedings of the National Academy of Sciences of the United States of America,4026,10.1073/pnas.93.12.5925,Sweden,Article,Huddinge,1,Journal,2-s2.0-0030579801
Yang N.,,"Estrogen-related receptor, hERR1, modulates estrogen receptor-mediated response of human lactoferrin gene promoter",1996,Journal of Biological Chemistry,184,10.1074/jbc.271.10.5795,United States,Article,Research Triangle Park,1,Journal,2-s2.0-0029965083
May F.,,Estrogen regulated messenger RNAs in human breast cancer cells,1995,Biomedicine and Pharmacotherapy,15,10.1016/0753-3322(96)82677-1,United Kingdom,Article,Newcastle,0,Journal,2-s2.0-0028803752
May F.E.B.,,The human cathepsin D-encoding gene is transcribed from an estrogen-regulated and a constitutive start point,1993,Gene,24,10.1016/0378-1119(93)90107-E,United Kingdom,Article,Newcastle,0,Journal,2-s2.0-0027138766
Schwabe J.,,The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: How receptors discriminate between their response elements,1993,Cell,567,10.1016/0092-8674(93)90390-C,United Kingdom,Article,Cambridge,0,Journal,2-s2.0-0027365669
Danielian P.S.,,Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors,1992,EMBO Journal,697,10.1002/j.1460-2075.1992.tb05141.x,United Kingdom,Article,London,1,Journal,2-s2.0-0026600841
Stewart A.,,Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells,1990,Journal of Biological Chemistry,376,,United Kingdom,Article,Newcastle,0,Journal,2-s2.0-0025635904
Berry M.,,Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence,1989,Proceedings of the National Academy of Sciences of the United States of America,285,10.1073/pnas.86.4.1218,France,Article,Paris,1,Journal,2-s2.0-0001235572
Henderson I.C.,,Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast Cancer,1988,New England Journal of Medicine,817,10.1056/NEJM198812293192601,,Article,,0,Journal,2-s2.0-0024269590
May F.,,Identification and characterization of estrogen-regulated RNAs in human breast cancer cells,1988,Journal of Biological Chemistry,73,,United Kingdom,Article,Newcastle,0,Journal,2-s2.0-0023686572
Giguère V.,,Identification of a new class of steroid hormone receptors,1988,Nature,631,10.1038/331091a0,United States,Article,Chevy Chase,0,Journal,2-s2.0-0023857147
May F.E.B.,,Cloning of estrogen-regulated messenger rna sequences from human breast cancer cells,1986,Cancer Research,74,,United Kingdom,Article,Newcastle,0,Journal,2-s2.0-0022840582
Klein-Hitpaß L.,,An estrogen-responsive element derived from the 5′ flanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells,1986,Cell,539,10.1016/0092-8674(86)90705-1,Germany,Article,Eggenstein-Leopoldshafen,0,Journal,2-s2.0-0023034983
Green S.,,Cloning of the human oestrogen receptor cDNA,1986,Journal of Steroid Biochemistry,226,10.1016/0022-4731(86)90035-X,France,Article,Paris,0,Journal,2-s2.0-0022922715
Walter P.,,Cloning of the human estrogen receptor cDNA,1985,Proceedings of the National Academy of Sciences of the United States of America,511,10.1073/pnas.82.23.7889,France,Article,Strasbourg,1,Journal,2-s2.0-0001063332
Schneider G.,,Increased estrogen production in obese men,1979,Journal of Clinical Endocrinology and Metabolism,336,10.1210/jcem-48-4-633,United States;United States,Article,;Newark,0,Journal,2-s2.0-0018365763
Jacobson H.I.,,Determination of tritium in biological material,1960,Archives of Biochemistry and Biophysics,12,10.1016/0003-9861(60)90374-X,United States,Article,Chicago,0,Journal,2-s2.0-50549157073
